MNPR Monopar Therapeutics Inc.
Fundamentals / CIK 0001645469 / USDMonopar Therapeutics Inc. reported $0 in revenue and a net loss of $20.60M for the fiscal year ended December 31, 2025.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MNPR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$0 Dec 31, 2025
-
Operating Income FY 2025-$25.49M Operating profit
-
Net Income FY 2025-$20.60M GAAP bottom line
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$105.1M Total debt: $357K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Research & Development | $9.90M | $13.01M | $5.60M | $7.59M | $6.49M | $4.07M | $1.97M | $1.77M | $935K | $280K |
| Total Operating Expenses | $16.70M | $16.16M | $8.83M | $10.54M | $9.13M | $6.51M | $4.32M | $3.33M | $16.60M | $1.19M |
| Operating Income | -$16.70M | -$16.16M | -$8.83M | -$10.54M | -$9.13M | -$6.51M | -$4.32M | -$3.33M | -$16.60M | -$1.19M |
| Interest Income | $2.99M | $404K | $429K | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$13.72M | -$15.59M | -$8.40M | -- | -- | -- | -- | -$3.30M | -$16.55M | -- |
| Income Tax Expense | $800 | $800 | $800 | $800 | $0 | $18K | $0 | -$71K | -$3.6K | $800 |
| Net Income | -$13.72M | -$15.59M | -$8.40M | -$10.52M | -$9.10M | -$6.30M | -$4.22M | -$3.23M | -$16.55M | -$1.19M |
| Basic EPS | -$1.85 | -$4.11 | -$3.04 | -$4.15 | -$3.65 | -$2.90 | -$2.25 | -$1.75 | -$9.45 | -- |
| Diluted EPS | -- | -- | -- | -- | -$3.65 | -$2.90 | -$2.25 | -$1.75 | -$9.45 | -- |
| Basic Shares Outstanding | 7.4M | 3.8M | 2.8M | 2.5M | 2.5M | 2.2M | 1.9M | 1.9M | 1.8M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | 2.5M | 2.2M | 1.9M | 1.9M | 1.8M | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Research & Development | $4.44M | $4.77M | $3.49M | $3.94M | $2.59M | $1.73M | $1.64M | $9.92M |
| Total Operating Expenses | $7.47M | $6.64M | $5.23M | $6.16M | $4.09M | $3.23M | $3.22M | $11.07M |
| Operating Income | -$7.47M | -$6.64M | -$5.23M | -$6.16M | -$4.09M | -$3.23M | -$3.22M | -$11.07M |
| Interest Income | $1.27M | $1.30M | $1.33M | $954K | $655K | $781K | $597K | $149K |
| Net Income | -$6.20M | -$5.31M | -$3.89M | -$5.20M | -$3.44M | -$2.45M | -$2.62M | -$10.93M |
| Basic EPS | -$0.72 | -$0.62 | -$0.46 | -- | -$0.48 | -$0.35 | -$0.38 | -- |
| Basic Shares Outstanding | 8.6M | 8.5M | 8.5M | -- | 7.1M | 7.0M | 7.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $61.83M | $45.82M | $7.27M | $8.19M | $20.30M | $16.74M | $13.21M | $6.89M | $8.98M | $2.07M |
| Short-Term Investments | $60.88M | $45.53M | $6.54M | $12.18M | -- | -- | -- | -- | -- | -- |
| Cash & Short-Term Investments | $122.7M | $91.35M | $13.81M | $12.18M | $20.01M | $16.74M | $13.21M | $6.89M | $8.98M | $2.07M |
| Other Current Assets | $64K | $79K | $66K | $46K | $218K | $63K | $16K | -- | -- | -- |
| Total Current Assets | $140.5M | $60.29M | $7.33M | $13.17M | $20.52M | $16.80M | $13.23M | $7.25M | $9.13M | $2.10M |
| Other Non-Current Assets | -- | -- | -- | -- | $0 | $69K | $122K | $66K | -- | -- |
| Total Non-Current Assets | $255K | $0 | $13K | $61K | $0 | $69K | $122K | $66K | $800K | $800K |
| Total Assets | $140.7M | $60.29M | $7.35M | $13.23M | $20.52M | $16.87M | $13.35M | $7.32M | $9.93M | $2.90M |
| Total Current Liabilities | $2.74M | $5.25M | $1.76M | $3.13M | $1.58M | $1.18M | $724K | $400K | $312K | $65K |
| Total Non-Current Liabilities | $155K | $0 | $0 | $8.4K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.89M | $5.25M | $1.76M | $3.14M | $1.58M | $1.18M | $724K | $400K | $312K | $65K |
| Total Debt (incl. Leases) | $245K | -- | $8.4K | $57K | -- | -- | -- | -- | -- | -- |
| Common Stock | $6.7K | $6.1K | $3.0K | $13K | $13K | $11K | $11K | $9.3K | $9.3K | $0 |
| Retained Earnings | -$89.51M | -$75.79M | -$60.21M | -$51.80M | -$41.29M | -$32.19M | -$25.88M | -$21.66M | -$18.43M | -$1.87M |
| Accumulated Other Comp. Income | $131K | $36K | -$14K | $8.9K | -$3.2K | -$7.9K | -$11K | -$2.4K | $0 | -- |
| Total Stockholders' Equity | $137.8M | $55.04M | $5.59M | $10.09M | $18.94M | $15.69M | $12.63M | $6.92M | $9.62M | $2.83M |
| Total Equity | $137.8M | $55.04M | $5.59M | $10.09M | $18.94M | $15.69M | $12.63M | $6.92M | $9.62M | $2.83M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $52.63M | $52.76M | $52.54M | $61.83M | $127.7M | $39.50M | $39.71M | $45.82M |
| Short-Term Investments | $52.49M | $52.61M | $52.37M | $60.88M | $127.5M | $39.33M | $39.51M | $45.53M |
| Cash & Short-Term Investments | $105.1M | $105.4M | $104.9M | $122.7M | $255.2M | $78.83M | $79.23M | $91.35M |
| Other Current Assets | $435K | $465K | $251K | $64K | $415K | $497K | $524K | $79K |
| Total Current Assets | $129.9M | $134.8M | $137.7M | $140.5M | $144.1M | $53.75M | $55.08M | $60.29M |
| Total Non-Current Assets | $367K | $215K | $240K | $255K | $107K | $118K | $9.1K | $0 |
| Total Assets | $130.2M | $135.0M | $138.0M | $140.7M | $144.2M | $53.87M | $55.09M | $60.29M |
| Total Current Liabilities | $2.98M | $4.02M | $2.46M | $2.74M | $2.57M | $1.58M | -- | $5.25M |
| Total Non-Current Liabilities | $200K | $108K | $132K | $155K | $71K | $80K | -- | $0 |
| Total Liabilities | $3.18M | $4.12M | $2.59M | $2.89M | $2.64M | $1.66M | $1.49M | $5.25M |
| Total Debt (incl. Leases) | $357K | $206K | $230K | $245K | $102K | $114K | $8.3K | -- |
| Common Stock | $6.8K | $6.7K | $6.7K | $6.7K | $6.7K | $6.1K | $6.1K | $6.1K |
| Retained Earnings | -$104.9M | -$98.72M | -$93.40M | -$89.51M | -$84.31M | -$80.87M | -$78.42M | -$75.79M |
| Accumulated Other Comp. Income | $95K | $91K | $99K | $131K | $12K | $78K | -$22K | $36K |
| Total Stockholders' Equity | $127.1M | $130.9M | $135.4M | $137.8M | $141.6M | $52.20M | $53.59M | $55.04M |
| Total Equity | $127.1M | $130.9M | $135.4M | $137.8M | $141.6M | $52.20M | $53.59M | $55.04M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$13.72M | -$15.59M | -$8.40M | -$10.52M | -$9.10M | -$6.30M | -$4.22M | -$3.23M | -$16.55M | -$1.19M |
| Stock-Based Compensation | $4.84M | $1.14M | $1.90M | $1.64M | $1.47M | $1.32M | $1.01M | $529K | $305K | $0 |
| Operating Cash Flow | -$12.20M | -$6.40M | -$7.86M | -$7.23M | -$7.32M | -$4.66M | -$3.02M | -$2.68M | -$2.63M | -$1.19M |
| Investing Cash Flow | -$63.45M | -$14.34M | $4.93M | -$4.92M | $0 | -- | -- | -- | -- | -- |
| Common Stock Issued | $0 | $4.20M | $2.07M | $109K | -- | $8.18M | $0 | $0 | $4.71M | $0 |
| Share Repurchases | -$35.00M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | $91.57M | $59.29M | $2.03M | $33K | $10.88M | $8.18M | $9.35M | -$206K | $9.54M | $1.26M |
| Net Change in Cash | $16.02M | $38.55M | -$920K | -$12.12M | $3.57M | $3.52M | $6.32M | -$2.89M | $6.91M | $68K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.20M | -$5.31M | -$3.89M | -$5.20M | -$3.44M | -$2.45M | -$2.62M | -$10.93M |
| Stock-Based Compensation | $2.04M | $1.43M | $1.69M | $1.10M | $1.10M | $1.28M | $1.36M | $279K |
| Operating Cash Flow | -$6.17M | -$3.25M | -$3.47M | -$3.06M | -$2.41M | -$1.08M | -$5.66M | -$2.00M |
| Investing Cash Flow | $5.46M | $4.12M | -$5.58M | -$62.19M | -$2.13M | $1.19M | -$326K | -$14.34M |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $0 | $0 | $1.01M |
| Financing Cash Flow | $586K | -$647K | -$200K | -$699K | $92.71M | -$317K | -$116K | $56.14M |
| Net Change in Cash | -$123K | $214K | -$9.29M | -$65.84M | $88.18M | -$209K | -$6.10M | $39.80M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -10.0% | -28.3% | -150.4% | -104.2% | -48.1% | -40.2% | -33.5% | -46.7% | -172.1% | -41.9% |
| Return on Assets (ROA) | -9.7% | -25.9% | -114.4% | -79.5% | -44.4% | -37.4% | -31.6% | -44.1% | -166.7% | -40.9% |
| Current Ratio | 51.35x | 11.47x | 4.17x | 4.21x | 12.98x | 14.28x | 18.27x | 18.15x | 29.28x | 32.48x |
| Quick Ratio | 44.86x | 17.39x | 7.86x | 3.89x | 12.66x | 14.22x | 18.25x | 17.25x | 28.80x | 32.13x |
| Debt to Equity | 0.00x | -- | 0.00x | 0.01x | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -16.2% | -13.6% | -11.1% | -10.0% | -13.7% | -33.2% | -30.9% | -28.3% |
| Return on Assets (ROA) | -15.8% | -13.2% | -10.9% | -9.7% | -13.5% | -32.1% | -30.1% | -25.9% |
| Current Ratio | 43.55x | 33.56x | 56.04x | 51.35x | 56.10x | 33.94x | -- | 11.47x |
| Quick Ratio | 35.25x | 26.24x | 42.69x | 44.86x | 99.35x | 49.78x | -- | 17.39x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -- |